Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
β1-Adrenergic receptor deficiency in ghrelin-expressing cells causes hypoglycemia in susceptible individuals
Bharath K. Mani, … , Chelsea Hepler, Jeffrey M. Zigman
Bharath K. Mani, … , Chelsea Hepler, Jeffrey M. Zigman
Published August 22, 2016
Citation Information: J Clin Invest. 2016;126(9):3467-3478. https://doi.org/10.1172/JCI86270.
View: Text | PDF
Research Article Endocrinology

β1-Adrenergic receptor deficiency in ghrelin-expressing cells causes hypoglycemia in susceptible individuals

  • Text
  • PDF
Abstract

Ghrelin is an orexigenic gastric peptide hormone secreted when caloric intake is limited. Ghrelin also regulates blood glucose, as emphasized by the hypoglycemia that is induced by caloric restriction in mouse models of deficient ghrelin signaling. Here, we hypothesized that activation of β1-adrenergic receptors (β1ARs) localized to ghrelin cells is required for caloric restriction–associated ghrelin release and the ensuing protective glucoregulatory response. In mice lacking the β1AR specifically in ghrelin-expressing cells, ghrelin secretion was markedly blunted, resulting in profound hypoglycemia and prevalent mortality upon severe caloric restriction. Replacement of ghrelin blocked the effects of caloric restriction in β1AR-deficient mice. We also determined that treating calorically restricted juvenile WT mice with beta blockers led to reduced plasma ghrelin and hypoglycemia, the latter of which is similar to the life-threatening, fasting-induced hypoglycemia observed in infants treated with beta blockers. These findings highlight the critical functions of ghrelin in preventing hypoglycemia and promoting survival during severe caloric restriction and the requirement for ghrelin cell–expressed β1ARs in these processes. Moreover, these results indicate a potential role for ghrelin in mediating beta blocker–associated hypoglycemia in susceptible individuals, such as young children.

Authors

Bharath K. Mani, Sherri Osborne-Lawrence, Prasanna Vijayaraghavan, Chelsea Hepler, Jeffrey M. Zigman

×

Figure 7

Proposed models of caloric restriction–induced ghrelin secretion to restore glucose homeostasis and of beta blocker–induced hypoglycemia.

Options: View larger image (or click on image) Download as PowerPoint
Proposed models of caloric restriction–induced ghrelin secretion to rest...
(i) Caloric restriction acting through the CNS enhances sympathetic drive onto ghrelin cells that are distributed within the gastric mucosa. Norepinephrine released from the sympathetic nerve terminals activates β1ARs located on the ghrelin cells to induce ghrelin synthesis and secretion. (ii) In turn, the released acyl-ghrelin engages several processes, including GH secretion, that tend to limit falls in blood glucose. Reduced blood glucose can also stimulate a sympathetic response and, furthermore, (iii) can directly stimulate ghrelin cells to release ghrelin, although this direct stimulus only accounts for a fraction of the usual secretory response of ghrelin cells to caloric restriction. When body fat is depleted as a consequence of severe caloric restriction, the ghrelin cell β1AR–mediated release of ghrelin functions as a critical defense against marked falls in blood glucose, thereby promoting survival. (iv) Administration of beta blockers results in unintended blockade of ghrelin cell β1ARs, causing blunted ghrelin secretion. (v) When lack of normal ghrelin secretion caused by β1AR blockade is combined with food restriction, susceptible individuals, such as young children and probably also adults with cachexia or anorexia nervosa, become predisposed to developing life-threatening hypoglycemia.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts